{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:04:43Z","timestamp":1792112683906,"version":"4.4.0"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T00:00:00Z","timestamp":1613692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CNS Drugs"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1007\/s40263-020-00790-w","type":"journal-article","created":{"date-parts":[[2021,2,19]],"date-time":"2021-02-19T20:38:33Z","timestamp":1613767113000},"page":"283-289","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Psychotropic Drug-Induced Glaucoma: A Practical Guide to Diagnosis and Management"],"prefix":"10.1007","volume":"35","author":[{"given":"Neeranjali S.","family":"Jain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire W.","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanil R.","family":"Dhanji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Symes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,19]]},"reference":[{"issue":"2","key":"790_CR1","doi-asserted-by":"publisher","first-page":"127","DOI":"10.2165\/00002018-200831020-00003","volume":"31","author":"J Li","year":"2008","unstructured":"Li J, Tripathi RC, Tripathi BJ. Drug-induced ocular disorders. Drug Saf. 2008;31(2):127\u201341.","journal-title":"Drug Saf."},{"issue":"2","key":"790_CR2","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1097\/00055735-200304000-00002","volume":"14","author":"NG Congdon","year":"2003","unstructured":"Congdon NG, Friedman DS. Angle-closure glaucoma: impact, etiology, diagnosis, and treatment. Curr Opin Ophthalmol. 2003;14(2):70\u20133.","journal-title":"Curr Opin Ophthalmol."},{"issue":"1","key":"790_CR3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.amjmed.2010.08.011","volume":"124","author":"M Razeghinejad","year":"2011","unstructured":"Razeghinejad M, Myers J, Katz L. Iatrogenic glaucoma secondary to medications. Am J Med. 2011;124(1):20\u20135.","journal-title":"Am J Med."},{"issue":"1","key":"790_CR4","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5005\/jp-journals-10008-1100","volume":"6","author":"AK Khurana","year":"2012","unstructured":"Khurana AK, Khurana B, Khurana AK. Drug-induced angle-closure glaucoma. J Curr Glaucoma Pract. 2012;6(1):6\u20138.","journal-title":"J Curr Glaucoma Pract."},{"issue":"2","key":"790_CR5","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/ICU.0b013e32808738d5","volume":"18","author":"Y Lachkar","year":"2007","unstructured":"Lachkar Y, Bouassida W. Drug-induced acute angle-closure glaucoma. Curr Opin Ophthalmol. 2007;18(2):129\u201333.","journal-title":"Curr Opin Ophthalmol."},{"issue":"8","key":"790_CR6","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1038\/eye.2011.128","volume":"25","author":"M Razeghinejad","year":"2011","unstructured":"Razeghinejad M, Pro M, Katz L. Non-steroidal drug-induced glaucoma. Eye. 2011;25(8):971\u201380.","journal-title":"Eye."},{"issue":"1","key":"790_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1111\/j.1442-9071.2006.01365.x","volume":"35","author":"GC Lee","year":"2007","unstructured":"Lee GC, Tam CP, Danesh-Meyer HV, Myers JS, Katz LJ. Bilateral angle-closure glaucoma induced by sulphonamide-derived medications. Clin Exp Ophthalmol. 2007;35(1):55\u20138.","journal-title":"Clin Exp Ophthalmol."},{"issue":"1","key":"790_CR8","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.ophtha.2003.04.004","volume":"111","author":"F Fraunfelder","year":"2004","unstructured":"Fraunfelder F, Fraunfelder F, Keates EU. Topiramate-associated acute, bilateral, secondary angle-closure glaucoma. Ophthalmology. 2004;111(1):109\u201311.","journal-title":"Ophthalmology"},{"issue":"6","key":"790_CR9","doi-asserted-by":"publisher","first-page":"501","DOI":"10.2165\/11533180-000000000-00000","volume":"24","author":"S Richa","year":"2010","unstructured":"Richa S, Yazbek J-C. Ocular adverse effects of common psychotropic agents. CNS Drugs. 2010;24(6):501\u201326.","journal-title":"CNS Drugs"},{"issue":"2","key":"790_CR10","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1139\/I06-012","volume":"41","author":"J Levy","year":"2006","unstructured":"Levy J, Yagev R, Petrova A, Lifshitz T. Topiramate-induced bilateral angle-closure glaucoma. Can J Ophthalmol. 2006;41(2):221\u20135.","journal-title":"Can J Ophthalmol."},{"issue":"11","key":"790_CR11","first-page":"1721","volume":"119","author":"DJ Rhee","year":"2001","unstructured":"Rhee DJ, Goldberg MJ, Parrish RK. Bilateral angle-closure glaucoma and ciliary body swelling from topiramate. Arch Ophthalmol. 2001;119(11):1721\u20133.","journal-title":"Arch Ophthalmol."},{"issue":"1","key":"790_CR12","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0002-9394(03)00774-8","volume":"137","author":"JE Craig","year":"2004","unstructured":"Craig JE, Ong TJ, Louis DL, Wells JM. Mechanism of topiramate-induced acute-onset myopia and angle-closure glaucoma. Am J Ophthalmol. 2004;137(1):193\u20135.","journal-title":"Am J Ophthalmol."},{"key":"790_CR13","doi-asserted-by":"publisher","first-page":"117","DOI":"10.2147\/OPTH.S27695","volume":"6","author":"M-A Abtahi","year":"2012","unstructured":"Abtahi M-A, Abtahi S-H, Fazel F, Roomizadeh P, Etemadifar M, Jenab K, et al. Topiramate and the vision: a systematic review. Clin Ophthalmol (Auckland, NZ). 2012;6:117.","journal-title":"Clin Ophthalmol (Auckland, NZ)."},{"issue":"11","key":"790_CR14","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/eye.2009.93","volume":"23","author":"D Leung","year":"2009","unstructured":"Leung D, Leung H, Baig N, Kwan P, Kwong Y, Wong K, et al. Topiramate and asymptomatic ocular angle narrowing: a prospective pilot study. Eye. 2009;23(11):2079\u201381.","journal-title":"Eye."},{"issue":"1","key":"790_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3109\/02713683.2010.529540","volume":"36","author":"BT Ozturk","year":"2011","unstructured":"Ozturk BT, Genc E, Tokgoz M, Kerimoglu H, Genc BO. Ocular changes associated with topiramate. Curr Eye Res. 2011;36(1):47\u201352.","journal-title":"Curr Eye Res."},{"issue":"1","key":"790_CR16","doi-asserted-by":"publisher","first-page":"86","DOI":"10.3109\/09273948.2010.523805","volume":"19","author":"MH Jabbarpoor Bonyadi","year":"2011","unstructured":"Jabbarpoor Bonyadi MH, Soheilian R, Soheilian M. Topiramate-induced bilateral anterior uveitis associated with hypopyon formation. Ocul Immunol Inflamm. 2011;19(1):86\u20138.","journal-title":"Ocul Immunol Inflamm."},{"issue":"1","key":"790_CR17","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S0002-9394(01)01013-3","volume":"132","author":"JT Banta","year":"2001","unstructured":"Banta JT, Hoffman K, Budenz DL, Ceballos E, Greenfield DS. Presumed topiramate-induced bilateral acute angle-closure glaucoma. Am J Ophthalmol. 2001;132(1):112\u20134.","journal-title":"Am J Ophthalmol."},{"issue":"5","key":"790_CR18","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1016\/j.ajo.2011.10.018","volume":"153","author":"M Etminan","year":"2012","unstructured":"Etminan M, Maberley D, Mikelberg FS. Use of topiramate and risk of glaucoma: a case-control study. Am J Ophthalmol. 2012;153(5):827\u201330.","journal-title":"Am J Ophthalmol."},{"issue":"2","key":"790_CR19","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.ajo.2012.07.016","volume":"155","author":"J-D Ho","year":"2013","unstructured":"Ho J-D, Keller JJ, Tsai C-Y, Liou S-W, Chang C-J, Lin H-C. Topiramate use and the risk of glaucoma development: a population-based follow-up study. Am J Ophthalmol. 2013;155(2):336-341.e1.","journal-title":"Am J Ophthalmol."},{"issue":"11","key":"790_CR20","doi-asserted-by":"publisher","first-page":"749","DOI":"10.2165\/00002018-200326110-00002","volume":"26","author":"RC Tripathi","year":"2003","unstructured":"Tripathi RC, Tripathi BJ, Haggerty C. Drug-induced glaucomas. Drug Saf. 2003;26(11):749\u201367.","journal-title":"Drug Saf."},{"issue":"1","key":"790_CR21","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1001\/archopht.1994.01090130077021","volume":"112","author":"R Ritch","year":"1994","unstructured":"Ritch R, Krupin T, Henry C, Kurata F. Oral imipramine and acute angle-closure glaucoma. Arch Ophthalmol. 1994;112(1):67\u20138.","journal-title":"Arch Ophthalmol."},{"issue":"8999","key":"790_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/S0140-6736(96)90041-0","volume":"347","author":"R Schlingemann","year":"1996","unstructured":"Schlingemann R, Smit A, Lunel HV, Hijdra A. Amaurosis fugax on standing and angle-closure glaucoma with clomipramine. The Lancet. 1996;347(8999):465.","journal-title":"The Lancet."},{"issue":"1","key":"790_CR23","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1093\/bmb\/ldp042","volume":"93","author":"I Subak-Sharpe","year":"2010","unstructured":"Subak-Sharpe I, Low S, Nolan W, Foster PJ. Pharmacological and environmental factors in primary angle-closure glaucoma. Br Med Bull. 2010;93(1):125\u201343.","journal-title":"Br Med Bull."},{"issue":"4","key":"790_CR24","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1177\/106002809102500422","volume":"25","author":"S Ahmad","year":"1991","unstructured":"Ahmad S. Fluoxetine and glaucoma. DICP. 1991;25(4):436.","journal-title":"DICP."},{"issue":"8","key":"790_CR25","doi-asserted-by":"publisher","first-page":"475","DOI":"10.2165\/00023210-200418080-00001","volume":"18","author":"C Costagliola","year":"2004","unstructured":"Costagliola C, Parmeggiani F, Sebastiani A. SSRIs and intraocular pressure modifications. CNS Drugs. 2004;18(8):475\u201384.","journal-title":"CNS Drugs"},{"issue":"5","key":"790_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/eye.1999.196","volume":"13","author":"H Bennett","year":"1999","unstructured":"Bennett H, Wyllie A. Paroxetine and acute angle-closure glaucoma. Eye. 1999;13(5):691\u20132.","journal-title":"Eye."},{"issue":"7091","key":"790_CR27","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1136\/bmj.314.7091.1387","volume":"314","author":"T Eke","year":"1997","unstructured":"Eke T, Bates A. Acute angle-closure glaucoma associated with paroxetine. BMJ Br Med J. 1997;314(7091):1387.","journal-title":"BMJ Br Med J."},{"issue":"3","key":"790_CR28","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1136\/bjo.81.3.252","volume":"81","author":"JF Kirwan","year":"1997","unstructured":"Kirwan JF, Subak-Sharpe IAN, Teimory M. Bilateral acute angle-closure glaucoma after administration of paroxetine. Br J Ophthalmol. 1997;81(3):252.","journal-title":"Br J Ophthalmol."},{"issue":"3","key":"790_CR29","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1038\/eye.2000.106","volume":"14","author":"AC Browning","year":"2000","unstructured":"Browning AC, Reck AC, Chisholm LH, Nischal KK. Acute angle-closure glaucoma presenting in a young patient after administration of paroxetine. Eye. 2000;14(3):406\u20138.","journal-title":"Eye."},{"key":"790_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.4088\/JCP.v58n0307b","volume":"58","author":"CF Lewis","year":"1997","unstructured":"Lewis CF. Acute angle-closure glaucoma and paroxetine. J Clin Psychiatry. 1997;58:123\u20134.","journal-title":"J Clin Psychiatry."},{"issue":"12","key":"790_CR31","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1345\/aph.1Z440","volume":"35","author":"FJ Jim\u00e9nez-Jim\u00e9nez","year":"2001","unstructured":"Jim\u00e9nez-Jim\u00e9nez FJ, Ort\u00ed-Pareja M, Zurdo JM. Aggravation of glaucoma with fluvoxamine. Ann Pharmacother. 2001;35(12):1565\u20136.","journal-title":"Ann Pharmacother."},{"issue":"8","key":"790_CR32","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1136\/bjo.2006.107185","volume":"91","author":"P Massaoutis","year":"2007","unstructured":"Massaoutis P, Goh D, Foster P. Bilateral symptomatic angle-closure associated with a regular dose of citalopram, an SSRI antidepressant. Br J Ophthalmol. 2007;91(8):1086\u20137.","journal-title":"Br J Ophthalmol."},{"issue":"1","key":"790_CR33","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/1471-2415-5-23","volume":"5","author":"R Croos","year":"2005","unstructured":"Croos R, Thirumalai S, Hassan S, Davis JDR. Citalopram associated with acute angle-closure glaucoma: case report. BMC Ophthalmol. 2005;5(1):23.","journal-title":"BMC Ophthalmol."},{"key":"790_CR34","unstructured":"Adverse Drug Reactions Advisory Committee. Australian Adverse Drug Reactions Bulletin. 2001. p. 3."},{"issue":"3","key":"790_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.5005\/jp-journals-10078-1261","volume":"13","author":"MC Yang","year":"2019","unstructured":"Yang MC, Lin KY. Drug-induced acute angle-closure glaucoma: a review. J Curr Glaucoma Pract. 2019;13(3):104\u20139.","journal-title":"J Curr Glaucoma Pract."},{"issue":"7","key":"790_CR36","doi-asserted-by":"publisher","first-page":"936","DOI":"10.1177\/1060028014529645","volume":"48","author":"AS Shifera","year":"2014","unstructured":"Shifera AS, Leoncavallo A, Sherwood M. Probable association of an attack of bilateral acute angle-closure glaucoma with duloxetine. Ann Pharmacother. 2014;48(7):936\u20139.","journal-title":"Ann Pharmacother."},{"issue":"5","key":"790_CR37","doi-asserted-by":"publisher","first-page":"241","DOI":"10.5694\/j.1326-5377.2002.tb04386.x","volume":"176","author":"B Ng","year":"2002","unstructured":"Ng B, Sanbrook GMC, Malouf AJ, Agarwal SA. Venlafaxine and bilateral acute angle-closure glaucoma. Med J Aust. 2002;176(5):241.","journal-title":"Med J Aust."},{"issue":"1","key":"790_CR38","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/sj.eye.6701815","volume":"20","author":"D Ezra","year":"2006","unstructured":"Ezra D, Storoni M, Whitefield L. Simultaneous bilateral acute angle-closure glaucoma following venlafaxine treatment. Eye. 2006;20(1):128\u20139.","journal-title":"Eye."},{"issue":"4","key":"790_CR39","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1159\/000310619","volume":"209","author":"P Denis","year":"1995","unstructured":"Denis P, Charpentier D, Berros P, Touameur S. Bilateral acute angle-closure glaucoma after dexfenfluramine treatment. Ophthalmologica. 1995;209(4):223\u20134.","journal-title":"Ophthalmologica."},{"issue":"10","key":"790_CR40","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1097\/IJG.0000000000000742","volume":"26","author":"JTL Lee","year":"2017","unstructured":"Lee JTL, Skalicky SE, Lin M-L. Drug-induced myopia and bilateral angle-closure secondary to Zolmitriptan. J Glaucoma. 2017;26(10):954\u20136.","journal-title":"J Glaucoma."},{"issue":"3","key":"790_CR41","doi-asserted-by":"publisher","first-page":"121","DOI":"10.5694\/j.1326-5377.2005.tb06613.x","volume":"182","author":"MHP de Guzman","year":"2005","unstructured":"de Guzman MHP, Thiagalingam S, Ong PY, Goldberg I. Bilateral acute angle-closure caused by supraciliary effusions associated with venlafaxine intake. Med J Aust. 2005;182(3):121\u20133.","journal-title":"Med J Aust."},{"issue":"6","key":"790_CR42","doi-asserted-by":"publisher","first-page":"e692","DOI":"10.4088\/JCP.15m10038","volume":"77","author":"H-Y Chen","year":"2016","unstructured":"Chen H-Y, Lin C-L, Lai S-W, Kao C-H. Association of selective serotonin reuptake inhibitor use and acute angle-closure glaucoma. J Clin Psychiatry. 2016;77(6):e692\u20136.","journal-title":"J Clin Psychiatry."},{"issue":"10","key":"790_CR43","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1001\/jamaophthalmol.2015.2180","volume":"133","author":"RJ Symes","year":"2015","unstructured":"Symes RJ, Etminan M, Mikelberg FS. Risk of angle-closure glaucoma with bupropion and topiramate. JAMA Ophthalmol. 2015;133(10):1187\u20139.","journal-title":"JAMA Ophthalmol."},{"issue":"6","key":"790_CR44","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.1016\/j.ajo.2006.01.033","volume":"141","author":"JR Zelefsky","year":"2006","unstructured":"Zelefsky JR, Fine HF, Rubinstein VJ, Hsu IS, Finger PT. Escitalopram-induced uveal effusions and bilateral angle-closure glaucoma. Am J Ophthalmol. 2006;141(6):1144\u20137.","journal-title":"Am J Ophthalmol."},{"key":"790_CR45","first-page":"Doc29-Doc","volume":"10","author":"S Raj","year":"2020","unstructured":"Raj S, Kaur M, Srinivasarao K, Thattaruthody F, Kaushik S, Pandav SS. Mirtazapine-induced bilateral secondary angle-closure in a female. GMS Ophthalmol Cases. 2020;10:Doc29-Doc.","journal-title":"GMS Ophthalmol Cases."},{"issue":"3","key":"790_CR46","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1097\/JCP.0b013e31825420a1","volume":"32","author":"DP Seitz","year":"2012","unstructured":"Seitz DP, Campbell RJ, Bell CM, Gill SS, Gruneir A, Herrmann N, et al. Short-term exposure to antidepressant drugs and risk of acute angle-closure glaucoma among older adults. J Clin Psychopharmacol. 2012;32(3):403\u20137.","journal-title":"J Clin Psychopharmacol."},{"issue":"10","key":"790_CR47","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1002\/gps.4327","volume":"30","author":"A Achiron","year":"2015","unstructured":"Achiron A, Aviv U, Mendel L, Burgansky-Eliash Z. Acute angle-closure glaucoma precipitated by olanzapine. Int J Geriatr Psychiatry. 2015;30(10):1101\u20132.","journal-title":"Int J Geriatr Psychiatry."},{"issue":"2","key":"790_CR48","doi-asserted-by":"publisher","first-page":"e40","DOI":"10.1097\/IJG.0000000000000836","volume":"27","author":"E Shen","year":"2018","unstructured":"Shen E, Farukhi S, Schmutz M, Mosaed S. Acute angle-closure glaucoma associated with aripiprazole in the setting of plateau iris configuration. J Glaucoma. 2018;27(2):e40\u20133.","journal-title":"J Glaucoma."},{"issue":"10181","key":"790_CR49","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1016\/S0140-6736(18)32607-2","volume":"393","author":"M He","year":"2019","unstructured":"He M, Jiang Y, Huang S, Chang DS, Munoz B, Aung T, et al. Laser peripheral iridotomy for the prevention of angle-closure: a single-centre, randomised controlled trial. Lancet. 2019;393(10181):1609\u201318.","journal-title":"Lancet"},{"issue":"2","key":"790_CR50","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1097\/ICU.0b013e3282f444f5","volume":"19","author":"FM Rauscher","year":"2008","unstructured":"Rauscher FM, Parrish RK. Atypical angle-closures. Curr Opin Ophthalmol. 2008;19(2):107\u201314.","journal-title":"Curr Opin Ophthalmol."},{"issue":"6","key":"790_CR51","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1038\/sj.eye.6702741","volume":"21","author":"S Parthasarathi","year":"2007","unstructured":"Parthasarathi S, Myint K, Singh G, Mon S, Sadasivam P, Dhillon B. Bilateral acetazolamide-induced choroidal effusion following cataract surgery. Eye. 2007;21(6):870\u20132.","journal-title":"Eye."},{"issue":"2","key":"790_CR52","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/j.jcrs.2010.12.032","volume":"37","author":"R Mancino","year":"2011","unstructured":"Mancino R, Varesi C, Cerulli A, Aiello F, Nucci C. Acute bilateral angle-closure glaucoma and choroidal effusion associated with acetazolamide administration after cataract surgery. J Cataract Refract Surg. 2011;37(2):415\u20137.","journal-title":"J Cataract Refract Surg."},{"issue":"2","key":"790_CR53","doi-asserted-by":"publisher","first-page":"e89","DOI":"10.1016\/j.jemermed.2009.09.020","volume":"43","author":"KL Cole","year":"2012","unstructured":"Cole KL, Wang EE, Aronwald RM. Bilateral acute angle-closure glaucoma in a migraine patient receiving topiramate: a case report. J Emerg Med. 2012;43(2):e89\u201391.","journal-title":"J Emerg Med."},{"issue":"1","key":"790_CR54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1752-1947-5-33","volume":"5","author":"MC Willett","year":"2011","unstructured":"Willett MC, Edward DP. Refractory topiramate-induced angle-closure glaucoma in a man: a case report. J Med Case Rep. 2011;5(1):33.","journal-title":"J Med Case Rep."},{"issue":"6","key":"790_CR55","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.ajo.2006.01.021","volume":"141","author":"DJ Rhee","year":"2006","unstructured":"Rhee DJ, Ramos-Esteban JC, Nipper KS. Rapid resolution of topiramate-induced angle-closure glaucoma with methylprednisolone and mannitol. Am J Ophthalmol. 2006;141(6):1133\u20134.","journal-title":"Am J Ophthalmol."},{"issue":"11","key":"790_CR56","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1001\/archopht.126.11.1603","volume":"126","author":"AH Zalta","year":"2008","unstructured":"Zalta AH, Smith RT. Peripheral iridoplasty efficacy in refractory topiramate-associated bilateral acute angle-closure glaucoma. Arch Ophthalmol. 2008;126(11):1603\u20135.","journal-title":"Arch Ophthalmol."},{"issue":"8","key":"790_CR57","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/IJG.0b013e318098739b","volume":"16","author":"R Parikh","year":"2007","unstructured":"Parikh R, Parikh S, Das S, Thomas R. Choroidal drainage in the management of acute angle-closure after topiramate toxicity. J Glaucoma. 2007;16(8):691\u20133.","journal-title":"J Glaucoma."}],"container-title":["CNS Drugs"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-020-00790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40263-020-00790-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40263-020-00790-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,29]],"date-time":"2023-01-29T12:09:24Z","timestamp":1674994164000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40263-020-00790-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,19]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["790"],"URL":"https:\/\/doi.org\/10.1007\/s40263-020-00790-w","relation":{},"ISSN":["1172-7047","1179-1934"],"issn-type":[{"value":"1172-7047","type":"print"},{"value":"1179-1934","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,19]]},"assertion":[{"value":"27 December 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Neeranjali S. Jain, Claire W. Ruan, Shanil R. Dhanji, and Richard Symes have no conflicts of interest that are directly relevant to the content of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"No funding was used to assist with the preparation of this manuscript.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"NSJ primary manuscript author, literature review and editing. CWR editing. SRD literature review and editing. RS conceptualization, supervisor and editing.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}